Milan

East Rutherford-headquartered Cambrex announced Aug. 11, 2026, that it will build a new $30 million R&D facility at its site in Milan, Italy.
Aug 17, 2026

Cambrex invests $30M in new Italy R&D facility

East Rutherford-based Cambrex is investing $30M in a new Milan R&D facility, expanding drug development and manufacturing capabilities.